Table 3.
SARS-CoV-2 Sequences | FD Amino Acid (Using mol wt) | Cell Viability Min (arb. Units) |
Cell Viability Max (arb. Units) | Correlation Coeficient (Min to Max) |
---|---|---|---|---|
Orf6 (61 aa) | 2.0242 | 110.2 | 121.8 | −0.99 to −0.90 anti-corr |
Nsp6 (290 aa) | 1.9743 | 138.7 | 153.3 | |
Orf7a (122 aa) | 1.9594 | 151.05 | 166.95 | |
Amino acid entropy (using mol wt) | ||||
Orf6 (61 aa) | 3.8553 | 110.2 | 121.8 | 0.7026 to 0.998 |
Nsp6 (290 aa) | 4.0707 | 138.7 | 153.3 | |
Orf7a (122 aa) | 4.0418 | 151.05 | 166.95 | |
di-nucleotide ATCG/AUCG entropy | ||||
Orf6 (183 nt) | 3.6756 | 110.2 | 121.8 | 0.8444 to 0.9999 |
Nsp6 (870 nt) | 3.7715 | 138.7 | 153.3 | |
Orf7a (366 nt) | 3.8660 | 151.05 | 166.95 | |
mono-nucleotide ATCG/AUCG entropy | ||||
Orf6 (183 nt) | 1.8610 | 110.2 | 121.8 | 0.8538 to 0.9992 |
Nsp6 (870 nt) | 1.9161 | 138.7 | 153.3 | |
Orf7a (366 nt) | 1.9640 | 151.05 | 166.95 |